Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by ScienceFirston Apr 25, 2023 2:33pm
71 Views
Post# 35412952

RE:RE:RE:The other side of 74.5%

RE:RE:RE:The other side of 74.5%

GrahamB ... Don't want to deceive you but your posts are not useful as they are biased.

Never a single one of your posts constructive, neither positive.  Strange!  Abnormally strange.  Especially for someone that doesn't own the stock.

We know what type of personnality and especially what agenda is behind this; FUD

Past doesn't matter.  Focus is on sales.  And you wouldn't have a cardiologist write a report and lecture on a technology that is as useless as you want to depict it.  

We all know that procurement processes are lenghtly processes in hospitals.  A friend of mine is head of cardiology research.  He acknowledges the need for such RV technology.  

<< Previous
Bullboard Posts
Next >>